OBJECTIVES: The purpose of this study was to determine the extent to which effectiveness of cardiac and diabetes treatment strategies varies by patient age. BACKGROUND: The impact of age on the effectiveness of revascularization and hyperglycemia treatments has not been thoroughly investigated. METHODS: In the BARI 2D (Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes) trial, 2,368 patients with documented stable heart disease and type 2 diabetes were randomized to receive prompt revascularization versus initial medical therapy with deferred revascularization and insulin sensitization versus insulin provision for hyperglycemia treatment. Patients were followed for an average of 5.3 years. Cox regression and mixed models were used to investigate the effect of age and randomized treatment assignment on clinical and health status outcomes. RESULTS: The effect of prompt revascularization versus medical therapy did not differ by age for death (interaction p = 0.99), major cardiovascular events (interaction p = 0.081), angina (interaction p = 0.98), or health status outcomes. After intervention, participants of all ages had significant angina and health status improvement. Younger participants experienced a smaller decline in health status during follow-up than older participants (age by time interaction p < 0.01). The effect of the randomized glycemia treatment on clinical and health status outcomes was similar for patients of different ages. CONCLUSIONS: Among patients with stable heart disease and type 2 diabetes, the relative beneficial effects of a strategy of prompt revascularization versus initial medical therapy and insulin-sensitizing versus insulin-providing therapy on clinical endpoints, symptom relief, and perceived health status outcomes do not vary by age. Health status improved significantly after treatment for all ages, and this improvement was sustained longer among younger patients. (Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes [BARI 2D]; NCT00006305).
RCT Entities:
OBJECTIVES: The purpose of this study was to determine the extent to which effectiveness of cardiac and diabetes treatment strategies varies by patient age. BACKGROUND: The impact of age on the effectiveness of revascularization and hyperglycemia treatments has not been thoroughly investigated. METHODS: In the BARI 2D (Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes) trial, 2,368 patients with documented stable heart disease and type 2 diabetes were randomized to receive prompt revascularization versus initial medical therapy with deferred revascularization and insulin sensitization versus insulin provision for hyperglycemia treatment. Patients were followed for an average of 5.3 years. Cox regression and mixed models were used to investigate the effect of age and randomized treatment assignment on clinical and health status outcomes. RESULTS: The effect of prompt revascularization versus medical therapy did not differ by age for death (interaction p = 0.99), major cardiovascular events (interaction p = 0.081), angina (interaction p = 0.98), or health status outcomes. After intervention, participants of all ages had significant angina and health status improvement. Younger participants experienced a smaller decline in health status during follow-up than older participants (age by time interaction p < 0.01). The effect of the randomized glycemia treatment on clinical and health status outcomes was similar for patients of different ages. CONCLUSIONS: Among patients with stable heart disease and type 2 diabetes, the relative beneficial effects of a strategy of prompt revascularization versus initial medical therapy and insulin-sensitizing versus insulin-providing therapy on clinical endpoints, symptom relief, and perceived health status outcomes do not vary by age. Health status improved significantly after treatment for all ages, and this improvement was sustained longer among younger patients. (Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes [BARI 2D]; NCT00006305).
Authors: C J Mullany; M B Mock; M M Brooks; S F Kelsey; N M Keller; K Sutton-Tyrrell; K M Detre; R L Frye Journal: Ann Thorac Surg Date: 1999-02 Impact factor: 4.330
Authors: William E Boden; Robert A O'Rourke; Koon K Teo; Pamela M Hartigan; David J Maron; William J Kostuk; Merril Knudtson; Marcin Dada; Paul Casperson; Crystal L Harris; Bernard R Chaitman; Leslee Shaw; Gilbert Gosselin; Shah Nawaz; Lawrence M Title; Gerald Gau; Alvin S Blaustein; David C Booth; Eric R Bates; John A Spertus; Daniel S Berman; G B John Mancini; William S Weintraub Journal: N Engl J Med Date: 2007-03-26 Impact factor: 91.245
Authors: K R Lorig; D S Sobel; A L Stewart; B W Brown; A Bandura; P Ritter; V M Gonzalez; D D Laurent; H R Holman Journal: Med Care Date: 1999-01 Impact factor: 2.983
Authors: Karen P Alexander; Matthew T Roe; Anita Y Chen; Barbara L Lytle; Charles V Pollack; Joanne M Foody; William E Boden; Sidney C Smith; W Brian Gibler; E Magnus Ohman; Eric D Peterson Journal: J Am Coll Cardiol Date: 2005-09-29 Impact factor: 24.094
Authors: Koon K Teo; Steven P Sedlis; William E Boden; Robert A O'Rourke; David J Maron; Pamela M Hartigan; Marcin Dada; Vipul Gupta; John A Spertus; William J Kostuk; Daniel S Berman; Leslee J Shaw; Bernard R Chaitman; G B John Mancini; William S Weintraub Journal: J Am Coll Cardiol Date: 2009-09-29 Impact factor: 24.094
Authors: William S Weintraub; John A Spertus; Paul Kolm; David J Maron; Zefeng Zhang; Claudine Jurkovitz; Wei Zhang; Pamela M Hartigan; Cheryl Lewis; Emir Veledar; Jim Bowen; Sandra B Dunbar; Christi Deaton; Stanley Kaufman; Robert A O'Rourke; Ron Goeree; Paul G Barnett; Koon K Teo; William E Boden; G B J Mancini Journal: N Engl J Med Date: 2008-08-14 Impact factor: 91.245
Authors: Robert L Frye; Phyllis August; Maria Mori Brooks; Regina M Hardison; Sheryl F Kelsey; Joan M MacGregor; Trevor J Orchard; Bernard R Chaitman; Saul M Genuth; Suzanne H Goldberg; Mark A Hlatky; Teresa L Z Jones; Mark E Molitch; Richard W Nesto; Edward Y Sako; Burton E Sobel Journal: N Engl J Med Date: 2009-06-07 Impact factor: 91.245
Authors: Mark A Hlatky; Derek B Boothroyd; Dena M Bravata; Eric Boersma; Jean Booth; Maria M Brooks; Didier Carrié; Tim C Clayton; Nicolas Danchin; Marcus Flather; Christian W Hamm; Whady A Hueb; Jan Kähler; Sheryl F Kelsey; Spencer B King; Andrzej S Kosinski; Neuza Lopes; Kathryn M McDonald; Alfredo Rodriguez; Patrick Serruys; Ulrich Sigwart; Rodney H Stables; Douglas K Owens; Stuart J Pocock Journal: Lancet Date: 2009-03-19 Impact factor: 79.321